Your institution may have access to this item. Find your institution then sign in to continue.
Title
Correction to: A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.
Abstract
(K) Computer aided Scholl image analysis of the length of MAP2 immunoreactive neurites showing decreased neurite lengths in cells infected with wild-type and E83R -synuclein. (J) Computer aided analysis of levels of -synuclein showing increased immunoreactivity in cells infected with wild-type and E83R -synuclein. Treatment with NPT100-18A recovered neuritic length in cells expressing wild-type but not E83R -synuclein.